Literature DB >> 24723279

Multidrug-resistant tuberculosis with fluoroquinolone resistance: sinister association with other drugs and ominous implications for treatment.

Kanchan Ajbani1, Chaitali Nikam1, Anjali Shetty1, Rajeev Soman1, Camilla Rodrigues1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24723279      PMCID： PMC4305140          DOI： 10.1093/cid/ciu232

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Successful management of highly drug resistant tuberculosis with individualised drug susceptibility testing.

Authors:  Rajeev Soman; Preeti Pillai; Surabhi Madan; Anjali Shetty; Camilla Rodrigues
Journal:  J Assoc Physicians India       Date:  2014-07

Review 2.  New vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "reaching the un-reached".

Authors:  Kuldeep Singh Sachdeva; Ashok Kumar; Puneet Dewan; Ajay Kumar; Srinath Satyanarayana
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375
  2 in total
  2 in total

1.  Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman Mokaddas
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

2.  Tuberculosis Pathways to Care and Transmission of Multidrug Resistance in India.

Authors:  Sachin R Atre; Jayshri D Jagtap; Mujtaba I Faqih; Yogita K Dumbare; Trupti U Sawant; Sunil L Ambike; Jitendra S Bhawalkar; Sandeep K Bharaswadkar; Padmaja K Jogewar; Ramji S Adkekar; Balasaheb P Hodgar; Vaishali Jadhav; Nitin D Mokashi; Jonathan E Golub; Avika Dixit; Maha R Farhat
Journal:  Am J Respir Crit Care Med       Date:  2022-01-15       Impact factor: 21.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.